BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31348115)

  • 1. Risk Factors of Relapse After Successful Electroconvulsive Therapy for Taiwanese Patients With Major Depression.
    Yang WC; Lin CH; Chen CC
    J ECT; 2020 Jun; 36(2):106-110. PubMed ID: 31348115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship between Symptom Relief and Psychosocial Functional Improvement during Acute Electroconvulsive Therapy for Patients with Major Depressive Disorder.
    Lin CH; Yang WC
    Int J Neuropsychopharmacol; 2017 Jul; 20(7):538-545. PubMed ID: 28430980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
    Lin CH; Huang CJ; Chen CC
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):63-72. PubMed ID: 29228200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
    Lin HS; Lin CH
    J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy.
    Martínez-Amorós E; Cardoner N; Soria V; Gálvez V; Menchón JM; Urretavizcaya M
    J ECT; 2012 Jun; 28(2):92-7. PubMed ID: 22531201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
    Lin CH; Park C; McIntyre RS
    J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment-resistant depression.
    Lin CH; Yang WC; Chen CC; Cai WR
    Acta Psychiatr Scand; 2020 Aug; 142(2):121-131. PubMed ID: 32412097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of relapse with maintenance electroconvulsive therapy in elderly patients with major depressive episode.
    Rapinesi C; Kotzalidis GD; Serata D; Del Casale A; Scatena P; Mazzarini L; Caccia F; Brugnoli R; Carbonetti P; Fensore C; Girardi P
    J ECT; 2013 Mar; 29(1):61-4. PubMed ID: 23011573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive Therapy Versus Fluoxetine in Suicidal Resolution for Patients With Major Depressive Disorder.
    Lin CH; Chen CC; Huang CJ
    J ECT; 2020 Dec; 36(4):234-241. PubMed ID: 32205736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    Nordenskjöld A; von Knorring L; Ljung T; Carlborg A; Brus O; Engström I
    J ECT; 2013 Jun; 29(2):86-92. PubMed ID: 23303421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2006 Feb; 67(2):263-8. PubMed ID: 16566622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.
    Lin CH; Chen MC; Yang WC; Lane HY
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):225-233. PubMed ID: 26718791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical factors related to acute electroconvulsive therapy outcome for patients with major depressive disorder.
    Chen CC; Lin CH; Yang WC; Chen MC
    Int Clin Psychopharmacol; 2017 May; 32(3):127-134. PubMed ID: 28177952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Related to the Changes in Quality of Life for Patients With Depression After an Acute Course of Electroconvulsive Therapy.
    Huang CJ; Huang YH; Lin CH
    J ECT; 2017 Jun; 33(2):126-133. PubMed ID: 27668944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
    Yildiz A; Mantar A; Simsek S; Onur E; Gökmen N; Fidaner H
    J ECT; 2010 Jun; 26(2):104-10. PubMed ID: 19935091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy.
    Medda P; Mauri M; Fratta S; Ciaponi B; Miniati M; Toni C; Dell'Osso L; Perugi G
    J ECT; 2013 Sep; 29(3):179-88. PubMed ID: 23899721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
    Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study.
    Smith GE; Rasmussen KG; Cullum CM; Felmlee-Devine MD; Petrides G; Rummans TA; Husain MM; Mueller M; Bernstein HJ; Knapp RG; O'Connor MK; Fink M; Sampson S; Bailine SH; Kellner CH;
    J Clin Psychiatry; 2010 Feb; 71(2):185-93. PubMed ID: 20193646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of Continuation or Maintenance Electroconvulsive Therapy Caused by the COVID-19 Pandemic: A Naturalistic Study Investigating Relapse in Patients With Major Depressive Disorder.
    Van de Velde N; Geerts PJ; Tandt H; Vanderhasselt MA; Titeca K; Lemmens G
    J ECT; 2021 Dec; 37(4):230-237. PubMed ID: 34145171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.